Celldex Therapeutics reported $1.91M in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
AbbVie USD 72.86B 5.36B Mar/2026
Agenus USD 35.54M 2.34M Mar/2025
Amgen USD 57.32B 2.72B Mar/2026
Bristol-Myers Squibb USD 46.43B 711M Mar/2026
Celldex Therapeutics USD 1.91M 428K Mar/2026
Glaxosmithkline GBP 19.06B 1.31B Mar/2026
Nektar Therapeutics USD 0 0 Jun/2022
Northwest Biotherapeutics USD 32.94M 6.93M Sep/2023
Pfizer USD 63.19B 536M Jun/2026
Rigel Pharmaceuticals USD 59.69M 90K Jun/2024
Roche Holding CHF 33.03B 1.41B Jun/2025